Application 214341
- Type
- ANDA
- Sponsor
- ANNORA PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 90MG | No | No |
| 002 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 180MG | No | No |
| 003 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 360MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 31722-011 | Deferasirox | Deferasirox | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-012 | Deferasirox | Deferasirox | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-013 | Deferasirox | Deferasirox | Camber Pharmaceuticals, Inc. | ANDA | Current |